Nishadil
Signup Signin
Delhi | 25°C (windy)
A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review
Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File

Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File
A New Dawn for Alzheimer's: Biogen & Eisai Advance Leqembi Autoinjector for At-Home Use

A New Dawn for Alzheimer's: Biogen & Eisai Advance Leqembi Autoinjector for At-Home Use
FDA Greenlights At-Home Leqembi: A Game-Changer for Early Alzheimer's Treatment

FDA Greenlights At-Home Leqembi: A Game-Changer for Early Alzheimer's Treatment
Prothena's PRX012 Alzheimer's Drug Shines with 'Non-Competitive' Brain Swelling Rates, Offering New Hope

Prothena's PRX012 Alzheimer's Drug Shines with 'Non-Competitive' Brain Swelling Rates, Offering New Hope
Load more..